1-6 of 6
Anthony Shelton
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Mogamulizumab Combinations in Patients with Relapsing/Refractory Adult T-Cell Leukemia/Lymphoma (r/r ATLL)

Maya D. Srinivasan, Christopher Dittus, Areej El-Jawahri, Salvia Jain, Anthony Shelton, John Mark Sloan
Journal: Blood
Blood (2024) 144 (Supplement 1): 6405.
https://doi.org/10.1182/blood-2024-205425
Published: 2024
Journal Articles

Daratumumab, Pomalidomide and Dexamethasone (DPd) in Relapsed/ Refractory Light Chain Amyloidosis Previously Exposed to Daratumumab

Cara Rosenbaum, Michaela Liedtke, Paul Christos, Hyemin Kim, Kathleen Pogonowski, Natalie Agudo, Bruna Barroso, Anthony Shelton, Samantha Reilly, Courtney Gadbois, John Mark Sloan, Vaishali Sanchorawala, Anita D'Souza
Journal: Blood
Blood (2023) 142 (Supplement 1): 3402.
https://doi.org/10.1182/blood-2023-191133
Published: 2023
Journal Articles

Safety and Efficacy of Propylene Glycol-Free Melphalan (Evomela) in Patients with AL Amyloidosis Undergoing Autologous Stem Cell Transplantation: Preliminary Results of a Phase II Study

Shayna Sarosiek, John Mark Sloan, MD, Karen Quillen, MDMPH, Dina Brauneis, ANP, Ramon Cruz, Amanda Schulman, Salli Fennessey, Anthony Shelton, Vaishali Sanchorawala, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4578.
https://doi.org/10.1182/blood-2019-129095
Published: 2019
Journal Articles

Increases in B-type natriuretic peptide (BNP) during treatment with lenalidomide in AL amyloidosis

Umit Tapan, David C. Seldin, Kathleen T. Finn, Salli Fennessey, Anthony Shelton, Jerome B. Zeldis, Vaishali Sanchorawala
Journal: Blood
Blood (2010) 116 (23): 5071–5072.
https://doi.org/10.1182/blood-2010-09-305136
Published: 2010
Journal Articles

Durable hematologic complete responses can be achieved with lenalidomide in AL amyloidosis

Vaishali Sanchorawala, Kathleen T. Finn, Salli Fennessey, Anthony Shelton, Gheorghe Doros, Jerome B. Zeldis, David C. Seldin
Journal: Blood
Blood (2010) 116 (11): 1990–1991.
https://doi.org/10.1182/blood-2010-07-295485
Published: 2010
Journal Articles

Durable Responses to Lenalidomide (Revlimid®) in Patients with AL Amyloidosis: Follow Up of a Phase II Trial.

David C. Seldin, MD, PhD, Michael Rosenzweig, MD, Kathleen T. Finn, RN, NP, Salli Fennessey, Anthony Shelton, Jerome B. Zeldis, MD, Martha Skinner, MD, Vaishali Sanchorawala, MD
Journal: Blood
Blood (2007) 110 (11): 192.
https://doi.org/10.1182/blood.V110.11.192.192
Published: 2007